Compound Detail
CHEMBL438909
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL438909 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | QRYBHHIRDQQZFK-UHFFFAOYSA-N |
2
Targets
6
Activities
2
Assay Types
0
PK Parameters
5
Publications
0
Known Names
Molecular Properties
203.2
MW (Da)
1.88
ALogP
3
HBA
2
HBD
62.5
PSA (Ų)
0.78
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 4 meas. best 4.09
IC50 2 meas. best 4.15
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Unchecked CHEMBL612545 | IC50 | 4.15 | 4.15 | 70840.0 | 1 |
| Human immunodeficiency virus 1 CHEMBL378 | EC50 | 4.09 | 4.09 | 81670.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Unchecked | IC50 | = | 70840.0 | nM | 4.15 | Inhibition of HIV1 3B gp41 six-helix bundle formation after 30 mins by native-po... | 19053778 |
| Human immunodeficiency virus 1 | EC50 | = | 81670.0 | nM | 4.09 | Antiviral activity against HIV1 3B in human MT2 cells assessed as inhibition of ... | 19053778 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 19053778 | 10.1021/jm800869t | Unchecked | 2 |
| 18226912 | 10.1016/j.bmc.2007.12.034 | Unchecked | 1 |
| 19053778 | 10.1021/jm800869t | Human immunodeficiency virus 1 | 1 |
| 19053778 | 10.1021/jm800869t | MT2 | 1 |
| 309948 | 10.1021/jm00209a002 | Rattus norvegicus | 1 |
Data from ChEMBL 36 via Core Engine